, 2019 Subject Explanation and analysis of Management for second quarter 2019 Attention Directors and manager The Stock Exchange of Thailand Inter pharma Public Company Limited (“the Company”) would like

ที่ หทว No. Kor Bor Ror. 016/2019 November 11, 2019 President The Stock Exchange of Thailand Re : Entering transactions with connected parties for 2020 Dear Sir, Thai Wacoal Public Company Limited

Acc. 006/2019 November 11, 2019 To: The President The Stock Exchange of Thailand Subject: Management discussion and analysis (MD&A) for Quarter 3/2019 Dear Sir, S. Khonkaen Foods Public Company

2019 To : The President The Stock Exchange of Thailand Bangkok Chain Hospital Public Company Limited (the “Company”) would like to report the operating results of the Company and its subsidiaries

ended September 30, 2019 To The President and Director The Stock Exchange of Thailand Dear Sirs, Finansia Syrus Securities Public Company would like to disclose the reviewed consolidated and separate

วันที่ 14 สิงหาคม 2550 DEMCO Public Company Limited No. Demco AC004/2019 November 13, 2019 Subject : The company’s operating result for the 3rd quarter of year 2019 To : The president, The Stock

: President The Stock Exchange of Thailand According to JAS Asset Public Company Limited (the “Company”) Meeting Resolution No. 7/2019 on 11 November 2019, the resolution to certify the Company’s financial

November 14, 2019 Re: Clarification of the operating results of company and its subsidiaries for the three month period end March 31, 2019 To: President The Stock Exchange of Thailand K.C. Property

November 14, 2019 Re: Clarification of the operating results of company and its subsidiaries for the six months period end of June 30, 2019 To: President The Stock Exchange of Thailand K.C. Property

analysis for the three-month period ended September 30, 2019 To: Director and Manager of the Stock Exchange of Thailand Referring to the submission of reviewed financial statements for quarter 3/2019 of Wiik